Q4 2021 13F Holders as of 31 Dec 2021
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
149,544,182
-
Total 13F shares
-
45,418,262
-
Share change
-
+216,512
-
Total reported value
-
$1,079,557,657
-
Price per share
-
$23.77
-
Number of holders
-
104
-
Value change
-
+$3,680,968
-
Number of buys
-
47
-
Number of sells
-
42
Institutional Holders of Avidity Biosciences, Inc. - Common Stock (RNA) as of Q4 2021
As of 31 Dec 2021 Avidity Biosciences, Inc. - Common Stock (RNA) had 104 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 45,418,262 shares of stock of the company.
Largest 10 holders included PRICE T ROWE ASSOCIATES INC /MD/, RTW INVESTMENTS, LP, FMR LLC, BlackRock Inc., EcoR1 Capital, LLC, FEDERATED HERMES, INC., Cormorant Asset Management, LP, VANGUARD GROUP INC, Avidity Partners Management LP, and STATE STREET CORP.
This table shows 104 institutional shareholders of the security as of 31 Dec 2021.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.